Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies ; volume:13 ; number:1 ; day:17 ; month:10 ; year:2023 ; pages:1-12 ; date:12.2023
Scientific reports ; 13, Heft 1 (17.10.2023), 1-12, 12.2023

Creator: Alrouji, Mohammed
Benjamin, Lizy Sonia
Alhumaydhi, Fahad A.
Al Abdulmonem, Waleed
Baeesa, Saleh Salem
Rehan, Mohd
Shahwan, Moyad
Shamsi, Anas
Akhtar, Atiya

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-023-44956-0

URN: urn:nbn:de:101:1-2024021210022233417908

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Alrouji, Mohammed
Benjamin, Lizy Sonia
Alhumaydhi, Fahad A.
Al Abdulmonem, Waleed
Baeesa, Saleh Salem
Rehan, Mohd
Shahwan, Moyad
Shamsi, Anas
Akhtar, Atiya
SpringerLink (Online service)

Other Objects (12)

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches

Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis

Hochschulschrift

In-silico endovascular repair of abdominal aortic aneurysms

Hochschulschrift

In-Silico Endovascular Repair of Abdominal Aortic Aneurysms

In-Silico Design of an Anti-Cancer Vaccine

In-silico identification of phenotype-biased functional modules

Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox

In-silico guided chemical exploration of KDM4A fragments hits

High throughput in-silico screening against flexible protein receptors

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches

Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis

Hochschulschrift

In-silico endovascular repair of abdominal aortic aneurysms

Hochschulschrift

In-Silico Endovascular Repair of Abdominal Aortic Aneurysms

In-Silico Design of an Anti-Cancer Vaccine

In-silico identification of phenotype-biased functional modules

Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox

In-silico guided chemical exploration of KDM4A fragments hits

High throughput in-silico screening against flexible protein receptors

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches

Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis

Hochschulschrift

In-silico endovascular repair of abdominal aortic aneurysms

Hochschulschrift

In-Silico Endovascular Repair of Abdominal Aortic Aneurysms

In-Silico Design of an Anti-Cancer Vaccine

In-silico identification of phenotype-biased functional modules

Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox

In-silico guided chemical exploration of KDM4A fragments hits

High throughput in-silico screening against flexible protein receptors

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Improving in-silico normalization using read weights

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches

Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis

In-silico endovascular repair of abdominal aortic aneurysms

In-Silico Endovascular Repair of Abdominal Aortic Aneurysms

In-Silico Design of an Anti-Cancer Vaccine

In-silico identification of phenotype-biased functional modules

Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox

In-silico guided chemical exploration of KDM4A fragments hits

High throughput in-silico screening against flexible protein receptors

Improving in-silico normalization using read weights

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches

Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis

In-silico endovascular repair of abdominal aortic aneurysms

In-Silico Endovascular Repair of Abdominal Aortic Aneurysms

In-Silico Design of an Anti-Cancer Vaccine

In-silico identification of phenotype-biased functional modules

Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox

In-silico guided chemical exploration of KDM4A fragments hits

High throughput in-silico screening against flexible protein receptors

Improving in-silico normalization using read weights

Improving in-silico normalization using read weights

Systems patientomics: the virtual in-silico patient

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches

Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis

In-silico endovascular repair of abdominal aortic aneurysms

In-Silico Endovascular Repair of Abdominal Aortic Aneurysms

In-Silico Design of an Anti-Cancer Vaccine

In-silico identification of phenotype-biased functional modules

Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox

In-silico guided chemical exploration of KDM4A fragments hits

High throughput in-silico screening against flexible protein receptors

Related objects

Reset password